Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00466518 · ClinicalTrials.gov registry record · NA
Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00466518 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 16 participants.
The verdict
NCT00466518, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is designed to look at the effect sitagliptin has on tacrolimus and sirolimus drug levels in kidney transplant patients. It is also designed to look at the side effects experienced in the transplant population.
Interventions
- DRUG Administration of sitagliptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00466518
The ClinicalTrials.gov registry entry for NCT00466518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Administration of sitagliptin is the first listed.
NCT00466518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00466518 about?
NCT00466518 is a clinical study titled "Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant". This study is designed to look at the effect sitagliptin has on tacrolimus and sirolimus drug levels in kidney transplant patients. It is also designed to look at the side effects experienced in the transplant population.
What is the current status of trial NCT00466518?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00466518?
The interventions under investigation include: Administration of sitagliptin (DRUG).
Who is sponsoring clinical trial NCT00466518?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.